3 Reasons to Sell TNDM and 1 Stock to Buy Instead
Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and ...
Beta Bionics, Inc.: Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...